GTH News and Press, Genetron Holdings Limited From 10/11/23

2023-10-11 17:00:27 ET More on Genetron Holdings Financial information for Genetron Holdings For further details see: Genetron Holdings enters into merger agreement to go private

Advanced Health Intelligence Ltd ADS (AHI) is expected to report for quarter end 2023-06-30 Home Bistro Inc (HBIS) is expected to report for quarter end 2023-07-31 Karooooo Ltd. (KARO) is expected to report $0.29 for Q2 2024 Winmark Corporation (WINA) is expected to report for Q4 2023...

Genetron Holdings Limited (GTH) is expected to report for quarter end 2023-06-30

2023-05-24 05:34:17 ET Genetron ( NASDAQ: GTH ) received Nasdaq notice dated May 17, 2023, indicating that for the last 30 consecutive business days, the closing bid price for the company’s ADSs was below the minimum bid price of $1.00 per share. The notice has no c...

Genetron Holdings ( NASDAQ: GTH ) has regained compliance with Nasdaq minimum bid price requirement. For the ten consecutive business days, from December 29, 2022 to January 13, 2023, the closing bid price of the company’s ADSs has been at $1.00 per share or ...

BEIJING, Jan. 18, 2023 (GLOBE NEWSWIRE) -- Genetron Holdings Limited ("Genetron Health" or the "Company", NASDAQ: GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screening products and companion diagnostics developm...

Beijing-based Genetron ( NASDAQ: GTH ) received a notice from Nasdaq for not being in compliance with the exchange's $1 minimum bid price requirement for continued listing. The company's American depositary shares (ADSs) were below the $1 per ADS mark for 30 ...

BEIJING, Nov. 07, 2022 (GLOBE NEWSWIRE) -- Genetron Holdings Limited ("Genetron Health" or the "Company", NASDAQ: GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screening products and companion diagnostics de...

Genetron Holdings press release ( NASDAQ: GTH ): Q2 GAAP EPS of -$0.08. Revenue of $20.56M (-5.5% Y/Y). LDT revenue was $17.1 million IVD revenue was $1.4 million Development services revenue was US $2.0 million Shares -1.54% PM. For further detai...

BEIJING, Oct. 12, 2022 (GLOBE NEWSWIRE) -- Genetron Holdings Limited ("Genetron Health" or the "Company", NASDAQ: GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screening products and companion diagnostics de...